DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kubitza D, Berkowitz SD, Misselwitz F.
Evidence-based development and rationale for once-daily rivaroxaban dosing regimens across multiple indications.
Clin Appl Thromb Hemost 2016;
22 (05) 412-422
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.